A study to evaluate the role of procalcitonin as a sepsis marker among elderly population

 

 

REFERENCES

1. Saransh Jain,Sanjeev Sinha,Surendra K Sharma:Procalcitonin as a prognostic marker of sepsis.BMC Research Notes 2014, 7;458
2.  Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003, 348:1546–1554.
3. Grozdanovski K, Milenkovic Z, Demiri I, Spasovska K, Cvetanovska M, Kirova-Urosevic V: Early prognosis in patients with community-acquired severe sepsis and septic shock: analysis of 184 consecutive cases. Prilozi 2012, 33:105–116.
4. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP: The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273:117–123
5. Dinant GJ, Knottnerus JA, Van Wersch JW. Discriminating ability of the erythrocyte sedimentation rate: a prospective study in general practice. Br J Gen Pract 1991;41(350):365-70.
6. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998, 26:1001–1006
7. Guven H, Altintop L, Baydin A et al. Diagnostic value of procalcitonin levels as an early indicator of sepsis. Am J Emerg Med 2002;20:202–206.
8. Clec’h C, Fosse J-P, Karoubi P, Vincent F, Chouahi I, Hamza L, Cupa M, Cohen Y: Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006, 34:102–107.
9. Meng F-S, Su L, Tang Y-Q, Wen Q, Liu Y-S, Liu Z-F: Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality. Clin Biochem 2009, 42:1025–1031.
10. Giamarellou H, Giamarellos-Bourboulis EJ, Repoussis P, Galani L, Anagnostopoulos N, Grecka P, Lubos D, Aoun M, Athanassiou K, Bouza E, Devigili E, Krçmery V, Menichetti F, Panaretou E, Papageorgiou E, Plachouras D: Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect 2004, 10:628–633.
11. Schröder J, Staubach K-H, Zabel P, Stüber F, Kremer B: Procalcitonin as a marker of severity in septic shock. Langenbeck’s Arch Surg 1999, 384:33–38.
12. Claeys R, Vinken S, Spapen H, Ver Elst K, Decochez K, Huyghens L, Gorus FK: Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002, 30:757–762.
13. Giamarellos-Bourboulis EJ, Mega A, Grecka P, Scarpa N, Koratzanis G, Thomopoulos G, Giamarellou H: Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002, 28:1351–1356.